west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "MA Hanying." 2 results
  • Treatment Strategy for Patients with Subacute Myocardial Infarction and Severe Ischemic and Functional Mitral Regurgitation

    Objective To investigate appropriate treatment strategy and timing for patients with subacute myocardial infarction and severe ischemic mitral regurgitation (IMR). Methods A total of 89 patients with subacute myocardial infarction and severe IMR underwent surgical treatment from January 2005 to December 2011 in Beijing Anzhen Hospital. There were 66 male patients and 23 female patients with their mean age of 64 (55-73) years. All the patients received only coronary artery bypass grafting (CABG) after 3 months of medication treatment without specific management for their IMR. Echocardiography was examined before medication treatment,preoperatively and 6 months after CABG to analyze their IMR degree and measure left ventricular end-systolic dimension (LVESD),left ventricular end diastolic dimension (LVEDD) and left ventricular ejection fraction (LVEF). Results There was no surgery-related death,perioperative myocardial ischemia or other severe postoperative complication. Eighty-one patients (91.0%) were followed up for 6-60 months. At 6 months after CABG,mitral regurgitation area (3.1±1.3 cm2 vs. 5.6±2.3 cm2),LVEDD (51.3±4.2 mm vs. 54.3±5.5 mm) and LVESD (31.7±3.9 mm vs. 34.6±4.3 mm) were significantly decreased than preoperative values (P<0.05),but LVEF was not statistically different from preoperative value (59.1%±3.9% vs. 58.9%±5.6%,P>0.05). From the third year during follow-up,all the patients received annual CT examination of their coronary artery,and no significant graft stenosis (graft stenosis>50%) was found. Conclusion With appropriately delayed CABG and right medication treatment,patients with subacute myocardial infarction and severe IMR may no longer need concomitant surgical management for their IMR, which can decrease surgical risks and reduce treatment cost.

    Release date:2016-08-30 05:45 Export PDF Favorites Scan
  • Impact of Choice of Prosthetic Heart Valves on Quality of Life for Elderly Patients after Mitral Valve Replacement:A Controlled Trial

    Objective To evaluate postoperative quality of life (QOL) of patients aged over 65 after mitral valvereplacement (MVR). Methods Ninety patients aged over 65 undergoing MVR by the same surgical group in Departmentof Cardiovascular Surgery of Anzhen Hospital were prospectively enrolled in this study. There were 62 male and 28 femalepatients with their age of 65-76 (68.6±6.8) years. There were 55 patients with hypertension,38 patients with type 2 diabetes,and all the patients had persistent atrial fibrillation. Nottingham Healthy Profile (NHP,Part I) and Duke Activity StatuIndex (DASI) were used to evaluate preoperative and postoperative QOL. According to the choice of prosthetic heart valves they received,all the patients were divided into two groups with 45 patients in each group: biological valve group and mechanical valve group. All the patients received MVR via the interatrial groove approach under general anesthesia and cardiopulmonary bypass. Mechanical valve replacement was performed using continuous suture without preserving the posterior leaflet of the mitral valve. Biological valve replacement was performed using interrupted suture and some of the posteriorleaflet of the mitral valve was routinely preserved. Patients in both groups underwent intraoperative bilateral pulmonary vein isolation and left atrial appendage ablation using a bipolar radiofrequency ablation device. The left atrial appendage was not excised or ligated. Results Postoperative QOL of all the patients was significantly better than preoperative QOL. There was no statistical difference in NHP and DASI at the 6th month after discharge between the 2 groups. But from the 1st year after discharge,QOL of the biological valve group was significantly better than that of the mechanical valve group. At the 3rd year after discharge,NHP and DASI of the mechanical valve group was not statistically different from those at the 1st year after discharge,but NHP and DASI of the biological valve group was significantly better than those at the 1st year after discharge. Conclusions QOL of elderly patients are significantly improved after MVR. Patients who receive biologicalvalve replacement may acquire better long-term QOL than patients who receive mechanical valve replacement.

    Release date:2016-08-30 05:47 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content